BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang HS, Hur M, Lee KR, Kim H, Kim HY, Kim JW, Chua MT, Kuan WS, Chua HR, Kitiyakara C, Phattharapornjaroen P, Chittamma A, Werayachankul T, Anandh U, Herath S, Endre Z, Horvath AR, Antonini P, Di Somma S; GREAT Network. Biomarker Rule-in or Rule-out in Patients With Acute Diseases for Validation of Acute Kidney Injury in the Emergency Department (BRAVA): A Multicenter Study Evaluating Urinary TIMP-2/IGFBP7. Ann Lab Med 2022;42:178-87. [PMID: 34635611 DOI: 10.3343/alm.2022.42.2.178] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Smit C, Sen S, von Dach E, Karmime A, Lescuyer P, Tonoli D, Bielicki J, Huttner A, Pfister M. Steering Away from Current Amoxicillin Dose Reductions in Hospitalized Patients with Impaired Kidney Function to Avoid Subtherapeutic Drug Exposure. Antibiotics (Basel) 2022;11:1190. [PMID: 36139969 DOI: 10.3390/antibiotics11091190] [Reference Citation Analysis]
2 Hasson D, Menon S, Gist KM. Improving acute kidney injury diagnostic precision using biomarkers. Practical Laboratory Medicine 2022. [DOI: 10.1016/j.plabm.2022.e00272] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
3 Yoon S, Kim J, Jeong K, Kim S. Acute Kidney Injury: Biomarker-Guided Diagnosis and Management. Medicina 2022;58:340. [DOI: 10.3390/medicina58030340] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Markarian T. Nouvelles approches diagnostiques de l’insuffisance rénale aiguë. Ann Fr Med Urgence 2022. [DOI: 10.3166/afmu-2022-0438] [Reference Citation Analysis]